CategoryHealth Benefits

Alan Evans

Alan Evans has reported that his spinoff, Biospective (a contract research organization that specializes in animal and human imaging), is a research outcome of Compute Canada. Dr. Evans has also 

Steven Hallam

Steven Hallam is the founder of the spinoff MetaMixis, a synthetic biology company that uses its software technology to expedite small molecule production. http://genomics.entrepreneurship.ubc.ca/training/entrepreneurial-education/lean-launch-pad/principal-investigator-steven-hallam-on-entrepreneurship-i-want-to-be-in-charge-of-my-own-destiny/ ith RAC support from Compute Canada, 

Nicolas Moitessier

Nicolas Moitessier created a spin-off, Molecular Forecaster Inc., a company that offers highly specialized drug design and discovery computer programs that aim to make several aspects of drug discovery faster 

Duane Cronin

Duane Cronin has filed a patent for a deformable energy-absorbing utility pole, which aims to make traffic and lighting poles safer and more stable in accidents. He is working with 

Gane Ka-Shu Wong

Gane Ka-Shu Wong is jointly appointed in the department of biological sciences and the Department of Medicine at the University of Alberta. He identifies and develops novel applications made possible 

Ghislain Deslongchamps

Ghislain Deslongchamps’s research is in computer-assisted molecular design, a field that can lead to highly potent and specific drugs. His work has yielded the inventions of Reverse-Docking, a new method 

Michael Bowling

Michael Bowling is behind artificial intelligence software and poker game products that have played against top poker players. His research could lead to other powerful real-world impact. http://webdocs.cs.ualberta.ca/~bowling/ ames have 

André Dieter Bandrauk

André Dieter Bandrauk, recently named Officer of the Order of Canada for his contributions to computational and theoretical chemistry, has pioneered a new field: attosecond science. http://www.usherbrooke.ca/medias/communiques/2012/mai/communiques-detail/c/18526/ dvances in modern 

Ping Liang

Ping Liang has created and made freely available software (pBWA) that can speed up large-scale analysis of personal genome data, which will lead to a better understanding of human genetics 

Julie Forman-Kay

Julie Forman-Kay researches proteins that do not follow a fixed three-dimensional structure. The understanding of these proteins, called intrinsically disordered proteins (IDPs), is an important part of understanding diseases such 

Mallar Chakravarty

Mallar Chakravarty’s research group has developed new algorithms to help analyze large quantities of mental-health data, in the hopes of better understanding how the anatomy of the brain changes shape 

Jacques Corbeil

Jacques Corbeil’s research is specifically focused on devising massively distributed software tools for the genomics community. He has created (and maintains) a parallel DNA sequencing tool called Ray, which is 

Chris Gray

Chris Gray conducts research on an antimicrobial peptide, which is considered a strong candidate for future antibiotic replacement. His work has the potential to affect drug discovery in this area. 

Mikko Karttunen

Mikko Karttunen studies small-scale interactions of biomolecules. The results of this research will enable the discovery of future drugs and therapeutic targets for many diseases. Karttunen’s research has led to 

Sergei Noskov

Sergei Noskov studies the transport across cellular membranes of ion and solute binding — a process that is not currently well understood and for which successful modelling could lead to 

Peter Tieleman

Peter Tieleman conducts research in biological membranes, a field that could inform the design of drugs. He has developed a new analysis software for membrane simulations, which he has made 

Holger Hoos

Holger Hoos has developed free-to-use, state-of-the-art software that includes ParaILS: a method for parameter tuning that has been used in dozens of academic and industrial applications. http://www.cs.ubc.ca/labs/beta/Projects/ParamILS/index.html he results of 

Seyed Moghadas

Seyed Moghadas’ research develops evidence-based decision models for protecting vulnerable Canadian populations from emerging infectious diseases. So far, it has yielded modelling software and a smartphone game system. http://abm-lab.yorku.ca/index.html his 

Michael Bowles

Michael Bowles is partnering with POS Biosciences to develop simulations that demonstrate and optimize the use of nano (very small) devices for the separation of particles based on size. These 

Man Kong Yau

Man Kong Yau is collaborating with Hydro Quebec to improve short-term forecasts of precipitation. This work can lead to better information about the impact of events such as hurricanes on 

Luc Beaulieu

Luc Beaulieu works in medical physics, researching algorithms for the effective distribution of doses in radiotherapy (commonly used to treat cancer). He has worked with the radiotherapy company Elekta to 

Top